Cryptococcal Disease Screening

Cryptococcal Disease Screening is a systematic diagnostic procedure, belonging to the genus of opportunistic infection prevention strategies, that specifically identifies asymptomatic or early-stage Cryptococcus species infection in immunocompromised individuals through targeted biological testing.

136

Publications

6.5K

Citations

797

Authors

313

Institutions

Publications per year

2017–2026

51

Publications

136

1–5 of 136

Authors

797

  1. DR
    David R. Boulware

    University of Minnesota, United States

    17 publications · 904 citations

    15

    h-index

  2. JN
    Joseph N Jarvis

    London School of Hygiene & Tropical Medicine, United Kingdom

    14 publications · 1.3K citations

    13

    h-index

  3. RR
    Radha Rajasingham

    University of Minnesota, United States

    13 publications · 439 citations

    12

    h-index

  4. TS
    Thomas S. Harrison

    St George's, University of London, United Kingdom

    12 publications · 1.5K citations

    12

    h-index

  5. DB
    David B. Meya

    Makerere University, Uganda

    14 publications · 681 citations

    12

    h-index

1–5 of 797

Venues

  1. PLoS ONE

    16 publications · 580 citations

    15

    h-index

  2. Clinical Infectious Diseases

    CID · 11 publications · 1.4K citations

    11

    h-index

  3. PubMed

    Repository · 11 publications · 344 citations

    10

    h-index

  4. Journal of Clinical Microbiology

    JCM · 8 publications · 303 citations

    8

    h-index

  5. Journal of Infection

    5 publications · 260 citations

    5

    h-index

1–5